Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins.
The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.
Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.
However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.
In 2019, the market size of Paediatric Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Paediatric Vaccine.
This report studies the global market size of Paediatric Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Paediatric Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Market Segment by Product Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
The global paediatric vaccine market is expected to grow at a healthy CAGR in next few years.
Increase in growth would be primarily attributed to improved understanding of immunology, which has resulted in launch of new vaccines products. Technological breakthrough has led to development of new vaccine class such as DNA vaccines, vector vaccines, intranasal vaccines, mucosal vaccines and others.
However, manufacturing complexity and stringent regulatory compliance are the factors that hinder the market growth. Refusal to immunization and vaccines shortages are other restraints for this market.
In 2019, the market size of Paediatric Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Paediatric Vaccine.
This report studies the global market size of Paediatric Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Paediatric Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GlaxoSmithCline
Merck
Sanofi
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly
Pfizer
F. Hoffmann-La Roche
Novo Nordisk
Market Segment by Product Type
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Paediatric Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Pneumococcal
1.3.3 Varicella
1.3.4 Combinations
1.3.5 Poliovirus
1.3.6 Hepatitis
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Paediatric Vaccine Market Size Growth Rate by Type (2019-2025)
1.3.2 Pneumococcal
1.3.3 Varicella
1.3.4 Combinations
1.3.5 Poliovirus
1.3.6 Hepatitis
